SCHEMBL7954089

SCHEMBL7954089

Cc1ccc2cc(C(=O)NC=NN)n3c2c1C(=O)CC3

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8417579 0.97
SCHEMBL7960892 0.83
SCHEMBL7956081 0.81
SCHEMBL7954087 0.80 MCL1 (0.31) MCL1
SCHEMBL8416084 0.79
SCHEMBL8417576 0.78 POLB (0.31)
SCHEMBL7960925 0.76 HPGD (0.42) MCL1
SCHEMBL7952021 0.76 MCL1 (0.47) MCL1
SCHEMBL7966685 0.75 BRD4 (0.31)
SCHEMBL7947061 0.74 SRD5A1 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6271251-B1 CARDIOVASCULAR DISORDERS SUMITOMO PHARMACEUTICALS COMPANY LIMITED (JP) 2001-08-07 US disclosed
EP-0787728-A1 Substituted guanidine derivatives, process for production thereof, and pharmaceutical uses thereof SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1997-08-06 EP disclosed